Author Question: Recent evaluations of the Head Start program have indicated that the a. program has little or no ... (Read 118 times)

CQXA

  • Hero Member
  • *****
  • Posts: 546
Recent evaluations of the Head Start program have indicated that the
 
  a. program has little or no effect on children's performance in school.
  b. beneficial effects of the program do not appear until the third or fourth year of elementary school.
  c. program has resulted in long-lasting improvements in intellectual performance.
  d. program has yielded short-term benefits in improving children's performance in school.

Question 2

Which of the following is not a disadvantage of longitudinal studies?
 
  a. Participants may get better at taking the tests over time.
  b. There is the possibility of an age-history confound.
  c. There is the possibility of a cohort effect.
  d. They can be rather costly.



sokh

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library